Access Campaign
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the WTO
Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise to scale up access to lifesaving drug
EU, UK, Switzerland, Norway must stop blocking negotiations on landmark pandemic monopoly waiver
COVID-19: Governments must act fast on consensus supporting historic move to suspend monopolies during pandemic
Access to Medicines: In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic
